Clinical Trials Directory

Trials / Completed

CompletedNCT01182818

Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease

FASEP Fabry and Stroke Epidemiological Protocol RISK FACTORS IN ISCHEMIC STROKE PATIENTS WITH FABRY DISEASE AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGICAL PROTOCOL

Status
Completed
Phase
Study type
Observational
Enrollment
1,000 (actual)
Sponsor
University of Rostock · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

More than one million people in Europe suffer from a stroke every day. Normally older people have a stroke, but also a significant number of younger people between 18 and 55 years. Usually, these can only be explained for a minority by the classical risk factors such as diabetes, overweight and high blood pressure. New studies indicate that in about 1 - 2 % of the younger stroke patients the etiology can be an undiagnosed genetic disease, e.g. Fabry disease. Fabry disease is a lysosomal storage disorder known to cause vasculopathy. The purpose of this study is to determine in a large number of young stroke patients, how many strokes were caused by Fabry disease and what risk factors might be able to predict this disease.

Conditions

Timeline

Start date
2010-09-01
Primary completion
2012-04-01
Completion
2012-04-01
First posted
2010-08-17
Last updated
2012-06-14

Locations

14 sites across 2 countries: Germany, Poland

Source: ClinicalTrials.gov record NCT01182818. Inclusion in this directory is not an endorsement.

Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease (NCT01182818) · Clinical Trials Directory